IDEAYA Biosciences, Inc.
IDYA
$23.63
-$0.49-2.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.61% | -151.47% | 1.80% | -33.36% | -16.54% |
| Total Depreciation and Amortization | 76.21% | -36.46% | -7.75% | 1.39% | 5.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.37% | 18.61% | 24.50% | 154,800.00% | -100.22% |
| Change in Net Operating Assets | 23.19% | 251.30% | -114.50% | 395.04% | -164.41% |
| Cash from Operations | 50.40% | -147.10% | -49.73% | 24.95% | -84.49% |
| Capital Expenditure | -20.69% | -141.14% | 53.03% | 26.57% | -58.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.40% | -901.11% | -128.16% | 119.72% | -217.40% |
| Cash from Investing | 140.49% | -883.77% | -129.23% | 119.37% | -216.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 849.62% | -99.01% | 607.20% | -88.78% | 160.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | 849.62% | -99.04% | 631.19% | -88.78% | 147.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.44% | -245.47% | 190.19% | 253.80% | -1,035.48% |